[
  {
    "ts": null,
    "headline": "DexCom Pairs Its Glucose Monitor With ŌURA’s Smart Ring",
    "summary": "DexCom Pairs Its Glucose Monitor With ŌURA’s Smart Ring",
    "url": "https://finnhub.io/api/news?id=d1a9dd1c9ab5c9b9be24b2ef910e31e83e7bb2ae2963bf95df4223bc20264ad1",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732038300,
      "headline": "DexCom Pairs Its Glucose Monitor With ŌURA’s Smart Ring",
      "id": 134147481,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "DexCom Pairs Its Glucose Monitor With ŌURA’s Smart Ring",
      "url": "https://finnhub.io/api/news?id=d1a9dd1c9ab5c9b9be24b2ef910e31e83e7bb2ae2963bf95df4223bc20264ad1"
    }
  },
  {
    "ts": null,
    "headline": "DexCom Pairs Its Glucose Monitor With Oura’s Smart Ring",
    "summary": "DexCom Pairs Its Glucose Monitor With Oura’s Smart Ring",
    "url": "https://finnhub.io/api/news?id=830781c0cc89b5f56d45387993bc2fb7e21a80be80b615cc83be762c1f80745f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732020600,
      "headline": "DexCom Pairs Its Glucose Monitor With Oura’s Smart Ring",
      "id": 131486536,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "DexCom Pairs Its Glucose Monitor With Oura’s Smart Ring",
      "url": "https://finnhub.io/api/news?id=830781c0cc89b5f56d45387993bc2fb7e21a80be80b615cc83be762c1f80745f"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories stock outperforms competitors despite losses on the day",
    "summary": "Abbott Laboratories stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=7585da7c9ab8f9b1567d67187bf375b0a233ea5f9ff192cd1036fee6fa581472",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732034160,
      "headline": "Abbott Laboratories stock outperforms competitors despite losses on the day",
      "id": 131506887,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=7585da7c9ab8f9b1567d67187bf375b0a233ea5f9ff192cd1036fee6fa581472"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy?",
    "summary": "Based on the average brokerage recommendation (ABR), Abbott (ABT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?",
    "url": "https://finnhub.io/api/news?id=54cb5086850671e97c591e4b00a15d2437095b54aac788338c976fd52336550d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732026611,
      "headline": "Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy?",
      "id": 131493363,
      "image": "https://media.zenfs.com/en/zacks.com/71afbbc0512eb3c471136d93f39079c9",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Based on the average brokerage recommendation (ABR), Abbott (ABT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?",
      "url": "https://finnhub.io/api/news?id=54cb5086850671e97c591e4b00a15d2437095b54aac788338c976fd52336550d"
    }
  },
  {
    "ts": null,
    "headline": "How I Repurposed My Late Father's Trust Account",
    "summary": "I restructured my father's Trust for better diversification and risk reduction. See why I reduced Health Care and Consumer stocks and shifted to new sectors.",
    "url": "https://finnhub.io/api/news?id=15b16fcae92f6698a79d30b640741803fef606dc53bf6706d6ae2323f9f9d2f9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732019685,
      "headline": "How I Repurposed My Late Father's Trust Account",
      "id": 131478623,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/175431947/image_175431947.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "I restructured my father's Trust for better diversification and risk reduction. See why I reduced Health Care and Consumer stocks and shifted to new sectors.",
      "url": "https://finnhub.io/api/news?id=15b16fcae92f6698a79d30b640741803fef606dc53bf6706d6ae2323f9f9d2f9"
    }
  },
  {
    "ts": null,
    "headline": "IXJ: Healthcare Sector Dashboard For November",
    "summary": "November dashboard shows the healthcare sector is overvalued by 18% relative to 11-yr averages; pharma/biotech and healthcare equipment, the most overpriced.",
    "url": "https://finnhub.io/api/news?id=17b2ae374f72b898be1e13a220d648b578b5b9ae1db05e9f4365ec93e3d05504",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732007700,
      "headline": "IXJ: Healthcare Sector Dashboard For November",
      "id": 131471159,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/688000635/image_688000635.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "November dashboard shows the healthcare sector is overvalued by 18% relative to 11-yr averages; pharma/biotech and healthcare equipment, the most overpriced.",
      "url": "https://finnhub.io/api/news?id=17b2ae374f72b898be1e13a220d648b578b5b9ae1db05e9f4365ec93e3d05504"
    }
  }
]